De novo malignant disease after liver transplantation? Risk and surveillance strategies

Authors

  • Geoffrey W. McCaughan,

    Corresponding author
    1. Centenary Research Institute, A. W. Morrow Gastroenterology and Liver Center, Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia
    • Address reprint requests to Geoffrey W. McCaughan, M.B.B.S., F.R.A.C.P., Ph.D., Centenary Research Institute, A. W. Morrow Gastroenterology and Liver Center, Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales 2050, Australia. Telephone: +61 2 9565 6125; FAX: +61 2 9565 6101; E-mail g.mccaughan@centenary.usyd.edu.au

    Search for more papers by this author
  • Claire M. Vajdic

    1. Adult Cancer Program, University of New South Wales, Sydney, New South Wales, Australia
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Ancillary